comparative evaluation of intrathecal bupivacaine alone, sufentanil or butorphanol in combination with bupivacaine for endoscopic urological surgery

ABSTRACT

The objective of the present study was to compare the onset, degree and recovery time of sensory and motor block and hemodynamic effects of intrathecal bupivacaine alone and bupivacaine with sufentanil or butorphanol in endoscopic urological surgeries. In a randomized, double-blind study, 90 patients of either sex and age, belonging to ASA Grades I and II, scheduled for elective endoscopic urological surgeries under spinal anesthesia, were allocated into three groups of 30 each. Patients received either 2.5 ml of 0.5% hyperbaric buypivacaine 12.5 mg [Group A], 1.5 ml of 0.5% hyperbaric bupivacaine 7.5 mg with 10 ?g sufentanil [Group B] or 1.5 ml of 0.5% hyperbaric bupivacaine 7.5 mg with 25 ?g butorphanol [Group C]. Vital parameters, level, duration and regression of sensory block and motor block and side-effects were recorded and compared. Analysis of variance [ANOVA], post hoc test and Chi-square test were used. Intrathecal addition of sufentanil/butorphanol prolonged the duration of sensory block [DOSB] compared with bupivacaine alone [DOSB being 156.83 +/- 23.83 min, 170.87 +/- 22.21 min and 171.17 +/- 23.99 min in groups A, B and C, respectively] without altering the duration of motor blockade. Bromage score 3 was achieved in 100%, 90% and 54.4% patients in groups A, B and C, respectively. The time to first request for analgesia was 112 +/- 46.3 min, 323 +/- 65.0 min and 299 +/- 73.9 min in groups A, B and C, respectively. Complications were reduced by the addition of butorphanol, which also has a lower tendency than sufentanil to produce pruritus [60%].The analgesia was significantly prolonged in groups B and C; group C had a less-intense motor block. Complications were reduced by the addition of butorphanol, which also has a lower tendency than sufentanil to produce pruritus. Thus, this combination of butorphanol with low-dose bupivacaine is especially beneficial in the geriatric group of patients who have multiple co-morbid conditions